Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study
Gespeichert in:
| Veröffentlicht in: | International journal of cardiology 2016-01, Vol.202, p.954-955 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 955 |
|---|---|
| container_issue | |
| container_start_page | 954 |
| container_title | International journal of cardiology |
| container_volume | 202 |
| creator | Yu, Qi Su, Xingli Liu, Enqi |
| description | |
| doi_str_mv | 10.1016/j.ijcard.2015.10.016 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1735909228</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167527315305805</els_id><sourcerecordid>1735909228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-2864ddf66a18d926cef7fb27add4d8a4eda63adf9f47c42fdb9789ad0d004bdb3</originalsourceid><addsrcrecordid>eNqFkUGP0zAQhS0EYsvCP0DIRy4ptuPEyQVUVV0WaSUkdjlbjmdMXZI42Amo_x5HXThw4TTS03szet8Q8pqzLWe8fnfa-pM1EbaC8SpL2yw-IRveKFlwVcmnZJMVVVRClVfkRUonxphs2-Y5uRJ1JduqLjck7MPSA3Vm8L03PT2eJ4z2GHpMM8Y8Bm9omKaQkM5HpOBNh3P4hqO3FJ1DO9PgaJrN7McPdB-GAcc50TBSQ0f8Re93N4fbw-7LQ_YscH5JnjnTJ3z1OK_J15vDw_62uPv88dN-d1dY2ai5EE0tAVxdG95AK2qLTrlOKAMgoTESwdSlAdc6qawUDrpWNa0BBrljB115Td5e9k4x_FhyGT34ZLHvzYhhSZqrsmpZK0STrfJitTGkFNHpKfrBxLPmTK-o9UlfUOsV9apmMcfePF5YugHhb-gP22x4fzFg7vnTY9TJehwtgo8Zm4bg_3fh3wW295m76b_jGdMpLHHMDDXXSWim79d3r9_mVcmqhlXlbxF5qDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1735909228</pqid></control><display><type>article</type><title>Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Yu, Qi ; Su, Xingli ; Liu, Enqi</creator><creatorcontrib>Yu, Qi ; Su, Xingli ; Liu, Enqi</creatorcontrib><identifier>ISSN: 0167-5273</identifier><identifier>EISSN: 1874-1754</identifier><identifier>DOI: 10.1016/j.ijcard.2015.10.016</identifier><identifier>PMID: 26549563</identifier><language>eng</language><publisher>Netherlands: Elsevier Ireland Ltd</publisher><subject>Cardiovascular ; Diabetes ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes Mellitus, Type 2 - epidemiology ; Familial hypercholesterolemia ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Hyperlipoproteinemia Type II - drug therapy ; Hyperlipoproteinemia Type II - epidemiology ; Low-density lipoprotein receptor ; Male ; Statin</subject><ispartof>International journal of cardiology, 2016-01, Vol.202, p.954-955</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2015 Elsevier Ireland Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-2864ddf66a18d926cef7fb27add4d8a4eda63adf9f47c42fdb9789ad0d004bdb3</citedby><cites>FETCH-LOGICAL-c487t-2864ddf66a18d926cef7fb27add4d8a4eda63adf9f47c42fdb9789ad0d004bdb3</cites><orcidid>0000-0002-3558-8647</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijcard.2015.10.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26549563$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Qi</creatorcontrib><creatorcontrib>Su, Xingli</creatorcontrib><creatorcontrib>Liu, Enqi</creatorcontrib><title>Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study</title><title>International journal of cardiology</title><addtitle>Int J Cardiol</addtitle><subject>Cardiovascular</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Familial hypercholesterolemia</subject><subject>Female</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Hyperlipoproteinemia Type II - drug therapy</subject><subject>Hyperlipoproteinemia Type II - epidemiology</subject><subject>Low-density lipoprotein receptor</subject><subject>Male</subject><subject>Statin</subject><issn>0167-5273</issn><issn>1874-1754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUGP0zAQhS0EYsvCP0DIRy4ptuPEyQVUVV0WaSUkdjlbjmdMXZI42Amo_x5HXThw4TTS03szet8Q8pqzLWe8fnfa-pM1EbaC8SpL2yw-IRveKFlwVcmnZJMVVVRClVfkRUonxphs2-Y5uRJ1JduqLjck7MPSA3Vm8L03PT2eJ4z2GHpMM8Y8Bm9omKaQkM5HpOBNh3P4hqO3FJ1DO9PgaJrN7McPdB-GAcc50TBSQ0f8Re93N4fbw-7LQ_YscH5JnjnTJ3z1OK_J15vDw_62uPv88dN-d1dY2ai5EE0tAVxdG95AK2qLTrlOKAMgoTESwdSlAdc6qawUDrpWNa0BBrljB115Td5e9k4x_FhyGT34ZLHvzYhhSZqrsmpZK0STrfJitTGkFNHpKfrBxLPmTK-o9UlfUOsV9apmMcfePF5YugHhb-gP22x4fzFg7vnTY9TJehwtgo8Zm4bg_3fh3wW295m76b_jGdMpLHHMDDXXSWim79d3r9_mVcmqhlXlbxF5qDw</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Yu, Qi</creator><creator>Su, Xingli</creator><creator>Liu, Enqi</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3558-8647</orcidid></search><sort><creationdate>20160101</creationdate><title>Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study</title><author>Yu, Qi ; Su, Xingli ; Liu, Enqi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-2864ddf66a18d926cef7fb27add4d8a4eda63adf9f47c42fdb9789ad0d004bdb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cardiovascular</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Familial hypercholesterolemia</topic><topic>Female</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Hyperlipoproteinemia Type II - drug therapy</topic><topic>Hyperlipoproteinemia Type II - epidemiology</topic><topic>Low-density lipoprotein receptor</topic><topic>Male</topic><topic>Statin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Qi</creatorcontrib><creatorcontrib>Su, Xingli</creatorcontrib><creatorcontrib>Liu, Enqi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Qi</au><au>Su, Xingli</au><au>Liu, Enqi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study</atitle><jtitle>International journal of cardiology</jtitle><addtitle>Int J Cardiol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>202</volume><spage>954</spage><epage>955</epage><pages>954-955</pages><issn>0167-5273</issn><eissn>1874-1754</eissn><cop>Netherlands</cop><pub>Elsevier Ireland Ltd</pub><pmid>26549563</pmid><doi>10.1016/j.ijcard.2015.10.016</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-3558-8647</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0167-5273 |
| ispartof | International journal of cardiology, 2016-01, Vol.202, p.954-955 |
| issn | 0167-5273 1874-1754 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1735909228 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Cardiovascular Diabetes Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - epidemiology Familial hypercholesterolemia Female Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hyperlipoproteinemia Type II - drug therapy Hyperlipoproteinemia Type II - epidemiology Low-density lipoprotein receptor Male Statin |
| title | Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A57%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Could%20familial%20hypercholesterolemia%20oppose%20the%20diabetogenic%20effect%20of%20statin?%20Comments%20on%20a%20new%20SAFEHEART%20study&rft.jtitle=International%20journal%20of%20cardiology&rft.au=Yu,%20Qi&rft.date=2016-01-01&rft.volume=202&rft.spage=954&rft.epage=955&rft.pages=954-955&rft.issn=0167-5273&rft.eissn=1874-1754&rft_id=info:doi/10.1016/j.ijcard.2015.10.016&rft_dat=%3Cproquest_cross%3E1735909228%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1735909228&rft_id=info:pmid/26549563&rft_els_id=S0167527315305805&rfr_iscdi=true |